Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y016876 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y013347 | — |
no adverse event; Nurse called and reported PROQUAD and VARIVAX were inadvertently concomitantly administered to a patient. Caller stated no patient symptoms have been reported. No additional AE/no PQC reported.; This spontaneous report was received from a Nurse and refers to a 2-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-FEB-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y013347, expiration date: 02-AUG-2026) (1 dose), for an unknown indication and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (lot #Y016876, expiration date: 07-APR-2026), dose number 1, (1 dose), for prophylaxis. The suspected vaccines were inadvertently concomitantly administered to a patient (accidental overdose). Reported stated no patient symptoms have been reported.
sterile diluent